Literature DB >> 28187504

Extreme spermatogenesis failure: andrological phenotype and intracytoplasmic sperm injection outcomes.

P Plouvier1, A-L Barbotin2, F Boitrelle3, D Dewailly1, V Mitchell2,4, J-M Rigot4,5, V Lefebvre-Khalil2, G Robin1,4,5.   

Abstract

Patients with very low sperm count through direct sperm examination can exhibit extreme oligozoospermia or cryptozoospermia (after centrifugation). The management of these patients is a real challenge for both clinicians and biologists. In this retrospective and comparative cohort study, we compared the andrological phenotype of patients with extreme alterations of spermatogenesis and assessed whether the origin of spermatozoa (testicular or ejaculate) had any influence on intracytoplasmic sperm injection (ICSI) outcomes. A total of 161 ICSI cycles were performed using ejaculated spermatozoa from 75 patients with extreme oligozoospermia (EOS) or cryptozoospermia (CS) and 150 ICSI cycles using extracted testicular spermatozoa from 74 patients with non-obstructive azoospermia (NOA). Physical, hormonal, ultrasound assessments, and ICSI outcomes were performed in each group. Cryptorchidism was significantly more frequent in the NOA group (60.8% vs. 22.6%, p = 0.001). FSH levels were significantly higher [18.9 IU/L (5.9-27.0) vs. 15.3 IU/L (9.0-46.5), p = 0.001] and the majority of inhibin B levels measured were found mostly undetectable in the NOA group as compared to EOS/CS group (31.1% vs. 10.7%, p = 0.0004). Moreover, we found no significant differences in the respect to the fertilization rates (48.9% and 43.3%, p = 0.43), implantation rates (17.4% and 15.9%, p = 0.77), and percentage of top quality embryo (22.4% and 20.4%, p = 0.73) between the two groups. The clinical pregnancy rates per embryo transferred were comparable in both groups (28.3% and 27.4%, p = 0.89). In this study, we showed for the first time a different andrological phenotype between EOS/CS and NOA groups. Indeed, cryptorchidism was significantly more frequent with more severe endocrine parameters found in the NOA group. These results reflect a more profound alteration in spermatogenesis in NOA patients. However, there was no difference in ICSI outcomes between NOA and EOS/CS groups.
© 2017 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  andrological phenotype; cryptozoospermia; extreme oligozoospermia; intracytoplasmic sperm injection outcomes; non-obstructive azoospermia

Mesh:

Substances:

Year:  2017        PMID: 28187504     DOI: 10.1111/andr.12323

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  4 in total

1.  Comparison and outcomes of nonobstructive azoospermia patients with different etiology undergoing MicroTESE and ICSI treatments.

Authors:  Xiangfeng Chen; Yi Ma; Shasha Zou; Siqi Wang; Jin Qiu; Qian Xiao; Liang Zhou; Ping Ping
Journal:  Transl Androl Urol       Date:  2019-08

2.  Sperm origins and concentration do not impact the clinical outcomes in intracytoplasmic sperm injection cycles.

Authors:  Cen Yang; Ze-Hong Zhou; Dan-Ni Zheng; Xiao-Fei Xu; Jin Huang; Ying Lian; Jie Qiao
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

3.  Comparison of intracytoplasmic sperm injection (ICSI) outcomes in infertile men with spermatogenic impairment of differing severity.

Authors:  Ping Ping; Zhong Zheng; Yi Ma; Sha-Sha Zou; Xiang-Feng Chen
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

4.  Non-obstructive idiopathic azoospermia vs azoospermia with antecedents of cryptorchidism: ways and probabilities of becoming parents.

Authors:  Jacques Singh Sangwan; Claire Petit; Romane Sainte Rose; Cynthia Frapsauce; Laura Dijols; Jean Marc Rigot; Fabrice Guérif
Journal:  Basic Clin Androl       Date:  2021-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.